{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-016447","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2022-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.447629+00:00","generated_at":"2026-06-24T01:35:07.797334+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Alpha Teknova reports Q2 2022 revenue of $11.7M, up 41% YoY, updates 2022 outlook to $38-42M","bullets":["Q2 total revenue reached $11.7 million, a 41% increase from $8.3 million in Q2 2021.","Net loss for Q2 2022 was $6.2 million ($0.22 per diluted share), compared to net loss of $2.3 million ($0.52 per share) in Q2 2021.","Adjusted EBITDA was negative $4.9 million in Q2 2022, versus negative $1.5 million in Q2 2021.","Cash position of $64.7 million; company updates 2022 revenue guidance to $38-$42 million, implying ~13% mid-point growth excluding Sample Transport.","CEO cited lower-than-expected H2 revenue due to early-stage biopharma customers deferring large purchases."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-016447","json":"https://secwatch.observer/filing/0000950170-22-016447.json","markdown":"https://secwatch.observer/filing/0000950170-22-016447.md","text":"https://secwatch.observer/filing/0000950170-22-016447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017022016447/0000950170-22-016447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017022016447/tkno-20220810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:35:07.797334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}